5 out of 10 concussions go undiagnosed in youth sports
Neurolytixs has leveraged artificial intelligence to diagnose concussions with blood biomarkers within 48 hours of an incident
67 Yonge Street, Suite 701. Toronto, ON. Canada.
DEVELOPED IN PARTNERSHIP WITH
Product analytics answers your questions
Maecenas varius nunc a odio ultrices, non consectetur nunc scelerisque. Mauris nec condimentum est, id eleifend orci.
Better understand you customers
Explain the features and what it acompolishes. What does your company offer that will improve or solve a problem?
Toronto
© 2020 Neurolytixs Inc All rights reserved
ABOUT US
Neurolytixs leverages artificial intelligence to easily, quickly and precisely diagnose concussions with 96% accuracy within 48 hours of an incident using a finger prick
BRAIN HEALTH FOR THE NEXT GENERATION
Improve acquisition
Lacinia condimentum lectus dolor viverra nunc. Mauris quis condimentum orci. Curabitur hendrerit, felis vitae.
Drive customer retention
Curabitur quis purus congue ante interdum mattis sit amet at ante. Nulla volutpat, magna quis convallis tristique.
Between 1.7 and 3 million sports and recreation related concussions happen each year in the US
2 in 10 high-school athletes who play contact sports will suffer a concussion this year
Girls' soccer sees the second-most concussions of all high school sports
Incident Test
Shipping to a Neurolytixs laboratory
Incident test using a finger prick
Preventive removal from play after incident
Analysis
Baseline Test
Baseline test using a finger prick
Shipping to a Neurolytixs laboratory
Secure storage
Currently, concussions are diagnosed subjectively through physical, cognitive, and behavioural methodologies – threatening the long-term brain health of Canadian youth, athletes, and military personnel.
Source: UPMC Sports Medicine
The Science
Neurolytixs’ ground-breaking technology is revolutionizing concussion diagnosis. Our proprietary research has identified a number of blood biomarkers that accurately identify brain injury among patients. Developed by Dr. Doug Fraser, a professor, clinician scientist, and Fellow of the Royal College of Physicians and Surgeons of Canada, this technology is the first test of its kind to yield accuracy in concussion diagnosis.
DISCLAIMER: Neurolytixs is based on research to date and has not been reviewed by FDA or Health Canada. At the moment, Neurolytixs is an R&D company and is not to be used for concussion diagnosis
Toronto
67 Yonge Street, Suite 701. Toronto, ON. Canada.
ABOUT US
Neurolytixs has leveraged artificial intelligence to diagnose concussions with blood biomarkers test with within 48 hours of an incident
© 2020 Neurolytixs Inc All rights reserved
